Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (not Standard BioTools Inc.) on August 6, 2020. The filing serves to report the company's financial results for the second fiscal quarter of 2020. The registrant is incorporated in Delaware and its common stock trades on the Nasdaq Global Select Market under the symbol FLDM.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) containing the actual results. Consequently, the filing text does not provide clear values for:
- Revenue
- Net profit or loss
- Cash flow
- Profit margins
- Debt levels
- Liquidity positions
Material Changes
The filing text does not disclose specific material changes in financial condition or operations compared to the prior period. It only indicates that results for the second quarter of 2020 were issued via a press release.
Guidance, Outlook, and Risks
The text contains no management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It explicitly states that the information furnished in this report and the attached press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into future filings unless expressly stated.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net loss, cash position) by reviewing Exhibit 99.1 (the August 6, 2020 Press Release), as they are absent from this cover document.
- Confirm the company name is Fluidigm Corporation, noting the discrepancy with the metadata field "STANDARD BIOTOOLS INC."
- Check for any subsequent filings or updates regarding the second quarter of 2020 results.
- Review the full press release for any guidance or outlook statements not summarized in this 8-K.